Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer

By afschroeder • November 15, 2025

Sakowitz S, Tupper HI, Benjamin LN, Oh S, He T, Ronaghi R, Channick CL, Rosenberg BJ, Salehi-Rad R, Smith MI, Bando JM, Young TJ, Barjaktarvic I, Velez Velez MA, Gower A, Cummings AL, Goldman J, Lisberg AE, Garon EB, Yanagawa J, Cameron EA, Burt BM, Revels SL, Toste P, Lee JM, Lee A, Deng J, Lee H, Benharash P, Moghanaki D. Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer. Chest. 2025 Nov 12:S0012-3692(25)05681-8. doi: 10.1016/j.chest.2025.10.040. Epub ahead of print. PMID: 41238056.

Tags: Hematology/Oncology, Non-small cell lung cancer, Publications, Pulmonary, Critical Care & Sleep Medicine, Stereotactic Body Radiation Therapy, Surgery, Veterans Administration

Phase 2 Trial of 89Zr-Deferoxamine-Daratumumab for CD38-targeted Immuno-PET/CT Detection of Multiple Myeloma

Ulaner GA, Kuker RA, Diamond B, Hoffman J, Motwani P, Goldenson B, Homsi Y, Schiller G, Thomsen B, Vossen A, Kazandjian D, Landgren CO. Phase[...]

A CCL21 gene-modified dendritic cell vaccine combined with pembrolizumab in advanced non-small cell lung cancer: a phase I trial

Oh MS, Lisberg AE, Dumitras C, Tran LM, Salehi-Rad R, Krysan K, Lim RJ, Shabihkhani M, Romero T, Li S, Zeng W, Jing Z, Li[...]

Correction to: Utilizing natural language processing (NLP) to identify breast cancer-associated lung metastases from pathology reports to delineate characteristics of this site of recurrence

Valentín López JC, Ho A, Hughes KS, Bardia A, Vidula N. Correction to: Utilizing natural language processing (NLP) to identify breast cancer-associated lung metastases from[...]